Organon & (US:OGN) ZACKS·2025-12-22 23:51Company Performance - Organon (OGN) closed at $6.98, reflecting a +2.2% change from the previous day's closing price, outperforming the S&P 500's gain of 0.64% [1] - Over the past month, Organon shares have decreased by 5.14%, while the Medical sector and S&P 500 have increased by 2.25% and 3% respectively [1] Upcoming Financial Results - Organon is expected to report an EPS of $0.74, indicating a 17.78% decline compared to the same quarter last year [2] - Revenue is projected to be $1.53 billion, showing a 3.84% decrease from the year-ago quarter [2] Fiscal Year Estimates - For the entire fiscal year, earnings are estimated at $3.78 per share and revenue at $6.24 billion, reflecting changes of -8.03% and -2.55% respectively from the previous year [3] - Recent analyst estimate revisions suggest a positive outlook on Organon's business operations and profit generation capabilities [3] Valuation Metrics - Organon has a Forward P/E ratio of 1.81, which is significantly lower than the industry average Forward P/E of 15.44 [6] - The company has a PEG ratio of 1.4, compared to the Medical Services industry's average PEG ratio of 1.67 [7] Industry Ranking - The Medical Services industry, which includes Organon, has a Zacks Industry Rank of 156, placing it in the bottom 37% of over 250 industries [8] - Research indicates that industries in the top 50% outperform those in the bottom half by a factor of 2 to 1 [8]